126 related articles for article (PubMed ID: 19274491)
1. Interleukin-18 serum levels in inflammatory bowel diseases: correlation with disease activity and inflammatory markers.
Haas SL; Abbatista M; Brade J; Singer MV; Böcker U
Swiss Med Wkly; 2009 Mar; 139(9-10):140-5. PubMed ID: 19274491
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
4. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.
Wu Z; Bi Y
J Clin Lab Anal; 2022 Feb; 36(2):e24130. PubMed ID: 34997981
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
[TBL] [Abstract][Full Text] [Related]
6. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
7. The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease.
Lee HW; Chung SH; Moon CM; Che X; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Medicine (Baltimore); 2016 Jun; 95(23):e3772. PubMed ID: 27281077
[TBL] [Abstract][Full Text] [Related]
8. [Could the cytokines concentration be a marker of IBD activity and be useful in evaluation of IBD differentiation?].
Cieċko-Michalska I; Wierzbicka-Tutka I; Szczepanek M; Fedak D; Mach T
Przegl Lek; 2016; 73(5):301-4. PubMed ID: 29629745
[TBL] [Abstract][Full Text] [Related]
9. CD99 refers to the activity of inflammatory bowel disease.
Zhou G; Yang W; Yu L; Yu T; Liu Z
Scand J Gastroenterol; 2017 Mar; 52(3):359-364. PubMed ID: 27866429
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum Il-9 levels in inflammatory bowel disease.
Defendenti C; Sarzi-Puttini P; Saibeni S; Bollani S; Bruno S; Almasio PL; Declich P; Atzeni F
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):569-75. PubMed ID: 26377844
[TBL] [Abstract][Full Text] [Related]
12. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
14. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
[TBL] [Abstract][Full Text] [Related]
15. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
Kucharzik T; Stoll R; Lügering N; Domschke W
Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
[TBL] [Abstract][Full Text] [Related]
16. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-18 concentrations in patients with inflammatory bowel disease.
Furuya D; Yagihashi A; Komatsu M; Masashi N; Tsuji N; Kobayashi D; Watanabe N
J Immunother; 2002; 25 Suppl 1():S65-7. PubMed ID: 12048353
[TBL] [Abstract][Full Text] [Related]
18. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
19. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease.
Abautret-Daly Á; Dempsey E; Riestra S; de Francisco-García R; Parra-Blanco A; Rodrigo L; Medina C; Connor TJ; Harkin A
Int J Psychiatry Clin Pract; 2017 Sep; 21(3):221-230. PubMed ID: 28353360
[TBL] [Abstract][Full Text] [Related]
20. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
